|
業務類別
|
Biotechnology |
|
業務概覽
|
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody. |
| 公司地址
| 7 Times Square, 43rd Floor, New York, NY, USA, 10036 |
| 電話號碼
| +1 929 999-4055 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.dianthustx.com |
| 員工數量
| 92 |
| Mr. Marino Garcia |
President, Chief Executive Officer and Director |
美元 600.00K |
10/04/2025 |
| Dr. Simrat Randhawa, M.D. |
Chief Medical Officer |
美元 482.00K |
10/04/2025 |
| Mr. Adam M. Veness, Esq. |
Senior Vice President, General Counsel and Secretary |
-- |
10/04/2025 |
| Mr. Edward G. Carr |
Chief Accounting Officer |
-- |
10/04/2025 |
| Mr. Ryan Savitz |
Chief Financial Officer, Chief Business Officer and Treasurer |
美元 464.00K |
10/04/2025 |
|
|
| Mr. Simon Read |
Director |
22/05/2025 |
| Dr. Steven Joseph Romano, M.D. |
Independent Director |
10/04/2025 |
| Ms. Alison F. Lawton |
Chairman of the Board |
10/04/2025 |
| Ms. Anne M. McGeorge |
Independent Director |
10/04/2025 |
| Mr. Marino Garcia |
President, Chief Executive Officer and Director |
10/04/2025 |
| Mr. Sujay R. Kango |
Director |
05/03/2025 |
| Ms. Paula Soteropoulos |
Independent Director |
10/04/2025 |
| Dr. Jonathan Violin, M.B.A.,PhD |
Independent Director |
10/04/2025 |
|
|
|
|
